Skeletal Muscle PGC-1α1 Modulates Kynurenine Metabolism and Mediates Resilience to Stress-Induced Depression

Depression is a debilitating condition with a profound impact on quality of life for millions of people worldwide. Physical exercise is used as a treatment strategy for many patients, but the mechanisms that underlie its beneficial effects remain unknown. Here, we describe a mechanism by which skeletal muscle PGC-1α1 induced by exercise training changes kynurenine metabolism and protects from stress-induced depression. Activation of the PGC-1α1-PPARα/δ pathway increases skeletal muscle expression of kynurenine aminotransferases, thus enhancing the conversion of kynurenine into kynurenic acid, a metabolite unable to cross the blood-brain barrier. Reducing plasma kynurenine protects the brain from stress-induced changes associated with depression and renders skeletal muscle-specific PGC-1α1 transgenic mice resistant to depression induced by chronic mild stress or direct kynurenine administration. This study opens therapeutic avenues for the treatment of depression by targeting the PGC-1α1-PPAR axis in skeletal muscle, without the need to cross the blood-brain barrier.

[1]  T. Vos,et al.  Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010 , 2013, The Lancet.

[2]  Z. Arany.  PGC-1 coactivators and skeletal muscle adaptations in health and disease. , 2008, Current opinion in genetics & development.

[3]  B. Spiegelman,et al.  A PGC1α-dependent myokine that drives browning of white fat and thermogenesis , 2012, Nature.

[4]  M. Lindskog,et al.  Dysfunctional hippocampal activity affects emotion and cognition in mood disorders , 2012, Brain Research.

[5]  Zhen Yan,et al.  Repeated Stress Causes Cognitive Impairment by Suppressing Glutamate Receptor Expression and Function in Prefrontal Cortex , 2012, Neuron.

[6]  D. Tagle,et al.  Thermal stability, pH dependence and inhibition of four murine kynurenine aminotransferases , 2010, BMC Biochemistry.

[7]  G. Aghajanian,et al.  Synaptic Dysfunction in Depression: Potential Therapeutic Targets , 2012, Science.

[8]  P. Deyn,et al.  The kynurenine pathway in major depression: Haplotype analysis of three related functional candidate genes , 2011, Psychiatry Research.

[9]  C. Pittenger.  Disorders of memory and plasticity in psychiatric disease , 2013, Dialogues in clinical neuroscience.

[10]  J. Bajramovic,et al.  Differential expression of stress proteins in human adult astrocytes in response to cytokines , 2000, Journal of Neuroimmunology.

[11]  H. Anisman,et al.  Inflammatory Factors Contribute to Depression and Its Comorbid Conditions , 2012, Science Signaling.

[12]  K. Nair,et al.  Skeletal muscle aging and the mitochondrion , 2013, Trends in Endocrinology & Metabolism.

[13]  S Levine,et al.  Behavioral stress impairs long-term potentiation in rodent hippocampus. , 1987, Behavioral and neural biology.

[14]  E. Castrén.  Neuronal network plasticity and recovery from depression. , 2013, JAMA psychiatry.

[15]  G. Rajkowska,et al.  Decreased Expression of Synapse-Related Genes and Loss of Synapses in Major Depressive Disorder , 2012, Nature Medicine.

[16]  Jonathan E. Shoag,et al.  The transcriptional coactivator PGC-1α mediates exercise-induced angiogenesis in skeletal muscle , 2009, Proceedings of the National Academy of Sciences.

[17]  Jiandie D. Lin,et al.  Paradoxical effects of increased expression of PGC-1α on muscle mitochondrial function and insulin-stimulated muscle glucose metabolism , 2008, Proceedings of the National Academy of Sciences.

[18]  M. Ruth.  A PGC1–α–dependent myokine that drives brown–fat–like development of white fat and thermogenesis , 2012 .

[19]  B. Spiegelman,et al.  Skeletal Muscle Fiber-type Switching, Exercise Intolerance, and Myopathy in PGC-1α Muscle-specific Knock-out Animals* , 2007, Journal of Biological Chemistry.

[20]  C. Nemeroff,et al.  The role of corticotropin-releasing hormone in the pathophysiology of depression: therapeutic implications. , 2011, Current topics in medicinal chemistry.

[21]  D. Guttridge.  Faculty Opinions recommendation of Skeletal muscle fiber-type switching, exercise intolerance, and myopathy in PGC-1alpha muscle-specific knock-out animals. , 2007 .

[22]  B. Baune,et al.  Neuroimmunological effects of physical exercise in depression , 2012, Brain, Behavior, and Immunity.

[23]  Wolfgang Wurst,et al.  Dissecting the genetic effect of the CRH system on anxiety and stress-related behaviour. , 2005, Comptes rendus biologies.

[24]  R. Hen,et al.  Neurogenesis and generalization: a new approach to stratify and treat anxiety disorders , 2012, Nature Neuroscience.

[25]  X. Ni,et al.  Swimming exercise ameliorates depression-like behavior in chronically stressed rats: Relevant to proinflammatory cytokines and IDO activation , 2013, Behavioural Brain Research.

[26]  R. Schwarcz,et al.  Blood–Brain Barrier Transport of Kynurenines: Implications for Brain Synthesis and Metabolism , 1991, Journal of neurochemistry.

[27]  M. Lindskog,et al.  Dysfunctional astrocytic regulation of glutamate transmission in a rat model of depression , 2013, Molecular Psychiatry.

[28]  Jiandie D. Lin,et al.  Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. , 2002, Nature.

[29]  M. Rudnicki,et al.  bFGF and LIF signaling activates STAT3 in proliferating myoblasts. , 1996, Developmental genetics.

[30]  L. Nolte,et al.  Adaptations of skeletal muscle to exercise: rapid increase in the transcriptional coactivator PGC‐1 , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[31]  Silvia Salatino,et al.  The Peroxisome Proliferator-activated Receptor γ Coactivator 1α/β (PGC-1) Coactivators Repress the Transcriptional Activity of NF-κB in Skeletal Muscle Cells* , 2012, The Journal of Biological Chemistry.

[32]  Zubin Bhagwagar,et al.  Inflammation, Glutamate, and Glia in Depression: A Literature Review , 2008, CNS Spectrums.

[33]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .

[34]  R. Dantzer,et al.  From inflammation to sickness and depression: when the immune system subjugates the brain , 2008, Nature Reviews Neuroscience.

[35]  J. Zierath,et al.  Strenuous physical exercise adversely affects monocyte chemotaxis , 2010, Thrombosis and Haemostasis.

[36]  T. Peters,et al.  Facilitated physical activity as a treatment for depressed adults: randomised controlled trial , 2012, BMJ : British Medical Journal.

[37]  J. Manzanares,et al.  Depression‐resistant endophenotype in mice overexpressing cannabinoid CB2 receptors , 2010, British journal of pharmacology.

[38]  R. Schwarcz,et al.  Targeting kynurenine aminotransferase II in psychiatric diseases: promising effects of an orally active enzyme inhibitor. , 2014, Schizophrenia bulletin.

[39]  B. Pedersen,et al.  The Role of Exercise-Induced Myokines in Muscle Homeostasis and the Defense against Chronic Diseases , 2010, Journal of biomedicine & biotechnology.

[40]  R. Kvetňanský,et al.  Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[41]  A. Rush,et al.  Residual Symptoms in Depressed Outpatients Who Respond by 50% But Do Not Remit to Antidepressant Medication , 2011, Journal of clinical psychopharmacology.

[42]  Athina Markou,et al.  Assessing antidepressant activity in rodents: recent developments and future needs. , 2002, Trends in pharmacological sciences.

[43]  B. Cohen,et al.  Blockade of Astrocytic Glutamate Uptake in Rats Induces Signs of Anhedonia and Impaired Spatial Memory , 2010, Neuropsychopharmacology.

[44]  M. Schwarz,et al.  The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression , 2007, Molecular Psychiatry.

[45]  M. Palkovits.  [23] Punch sampling biopsy technique , 1983 .

[46]  G. Oxenkrug.  Insulin Resistance and Dysregulation of Tryptophan–Kynurenine and Kynurenine–Nicotinamide Adenine Dinucleotide Metabolic Pathways , 2013, Molecular Neurobiology.

[47]  K. Behar,et al.  Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole , 2010, Molecular Psychiatry.

[48]  B. Baune,et al.  Depression and type 2 diabetes: Inflammatory mechanisms of a psychoneuroendocrine co-morbidity , 2012, Neuroscience & Biobehavioral Reviews.

[49]  Christoph Handschin,et al.  Metabolic control through the PGC-1 family of transcription coactivators. , 2005, Cell metabolism.

[50]  D. O'Gorman,et al.  Acute exercise remodels promoter methylation in human skeletal muscle. , 2012, Cell metabolism.

[51]  R. Kreis,et al.  Transcriptional adaptations of lipid metabolism in tibialis anterior muscle of endurance-trained athletes. , 2003, Physiological genomics.

[52]  A. Sherman,et al.  l-Kynurenine Its synthesis and possible regulatory function in brain , 1980, Neurochemical Research.

[53]  Jiandie D. Lin,et al.  Transcriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibres , 2002, Nature.

[54]  R. Schwarcz,et al.  Kynurenines in the mammalian brain: when physiology meets pathology , 2012, Nature Reviews Neuroscience.

[55]  R. Porsolt,et al.  Depression: a new animal model sensitive to antidepressant treatments , 1977, Nature.

[56]  Yong-Ku Kim,et al.  Network beyond IDO in psychiatric disorders: Revisiting neurodegeneration hypothesis , 2014, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[57]  A. Bjørnebekk,et al.  Running is rewarding and antidepressive , 2007, Physiology & Behavior.

[58]  Debbie A Lawlor,et al.  The effectiveness of exercise as an intervention in the management of depression: systematic review and meta-regression analysis of randomised controlled trials , 2001, BMJ : British Medical Journal.

[59]  L. Lanfumey,et al.  Neurochemical and Behavioral Alterations in Glucocorticoid Receptor-Impaired Transgenic Mice after Chronic Mild Stress , 2004, The Journal of Neuroscience.

[60]  T. Connor,et al.  Poly I:C-induced activation of the immune response is accompanied by depression and anxiety-like behaviours, kynurenine pathway activation and reduced BDNF expression , 2013, Brain, Behavior, and Immunity.

[61]  R. Evans,et al.  Regulation of Muscle Fiber Type and Running Endurance by PPARδ , 2004, PLoS biology.

[62]  Jiandie D. Lin,et al.  Exercise induces hippocampal BDNF through a PGC-1α/FNDC5 pathway. , 2013, Cell metabolism.

[63]  C. Lloyd,et al.  Epidemiology of depression and diabetes: a systematic review. , 2012, Journal of affective disorders.

[64]  B. Czéh,et al.  Astroglial Plasticity in the Hippocampus is Affected by Chronic Psychosocial Stress and Concomitant Fluoxetine Treatment , 2006, Neuropsychopharmacology.

[65]  B. Spiegelman,et al.  A PGC-1α Isoform Induced by Resistance Training Regulates Skeletal Muscle Hypertrophy , 2012, Cell.

[66]  S. Carr,et al.  Metabolic Signatures of Exercise in Human Plasma , 2010, Science Translational Medicine.

[67]  G. Sanacora,et al.  Towards a glutamate hypothesis of depression An emerging frontier of neuropsychopharmacology for mood disorders , 2012, Neuropharmacology.

[68]  K. Nair,et al.  Impact of aerobic exercise training on age-related changes in insulin sensitivity and muscle oxidative capacity. , 2003, Diabetes.

[69]  R. Duman,et al.  A Neurotrophic Model for Stress-Related Mood Disorders , 2006, Biological Psychiatry.

[70]  H. Anisman,et al.  Effects of stressors and immune activating agents on peripheral and central cytokines in mouse strains that differ in stressor responsivity , 2011, Brain, Behavior, and Immunity.

[71]  P. Willner.  Chronic Mild Stress (CMS) Revisited: Consistency and Behavioural-Neurobiological Concordance in the Effects of CMS , 2005, Neuropsychobiology.

[72]  R. Hirschfeld.  History and evolution of the monoamine hypothesis of depression. , 2000, The Journal of clinical psychiatry.

[73]  G. Rajkowska,et al.  Gliogenesis and glial pathology in depression. , 2007, CNS & neurological disorders drug targets.

[74]  Nobumasa Kato,et al.  Gene expression profiling of major depression and suicide in the prefrontal cortex of postmortem brains , 2008, Neuroscience Research.

[75]  Douglas J Mahoney,et al.  Understanding skeletal muscle adaptation to exercise training in humans: contributions from microarray studies. , 2005, Physical medicine and rehabilitation clinics of North America.